ClearBridge Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

ClearBridge Investments’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,973	Closed	-$38K	–	1231
2018 Q1	$38K	Hold	1,973	–	–	﹤0.01%	883
2017 Q4	$33K	Buy	+1,973	New	+$36.2K	﹤0.01%	929

ClearBridge Investments's IPXL Position: Q2 2018 in Review

ClearBridge Investments sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,973 shares — an estimated $38K sold.

ClearBridge Investments first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $38K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

ClearBridge Investments reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
ClearBridge Investments sold 1,973 Impax Laboratories, Inc. shares in Q2 2018, an estimated $38K.
ClearBridge Investments first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
ClearBridge Investments's Impax Laboratories, Inc. position peaked at $38K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on ClearBridge Investments's 13F filing for Q2 2018, filed 14 Aug 2018.